DE69414947D1 - Dialyselösung zur extrakorporalen Hemodialyse - Google Patents
Dialyselösung zur extrakorporalen HemodialyseInfo
- Publication number
- DE69414947D1 DE69414947D1 DE69414947T DE69414947T DE69414947D1 DE 69414947 D1 DE69414947 D1 DE 69414947D1 DE 69414947 T DE69414947 T DE 69414947T DE 69414947 T DE69414947 T DE 69414947T DE 69414947 D1 DE69414947 D1 DE 69414947D1
- Authority
- DE
- Germany
- Prior art keywords
- dialysis solution
- renal
- composition
- extracorporeal hemodialysis
- nephrosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22538993 | 1993-09-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69414947D1 true DE69414947D1 (de) | 1999-01-14 |
DE69414947T2 DE69414947T2 (de) | 1999-07-08 |
Family
ID=16828600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69414947T Expired - Fee Related DE69414947T2 (de) | 1993-09-10 | 1994-09-07 | Dialyselösung zur extrakorporalen Hemodialyse |
Country Status (8)
Country | Link |
---|---|
US (1) | US5474992A (de) |
EP (1) | EP0643969B1 (de) |
KR (1) | KR950007845A (de) |
AT (1) | ATE173928T1 (de) |
CA (1) | CA2129509A1 (de) |
DE (1) | DE69414947T2 (de) |
ES (1) | ES2124348T3 (de) |
TW (1) | TW298566B (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2244535A1 (en) * | 1995-05-15 | 2000-01-30 | Avon Products, Inc. | Novel uses for ascorbyl-phosphoryl-cholesterol in topical compositions |
US6162450A (en) * | 1995-05-15 | 2000-12-19 | Avon Products, Inc. | Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same |
US6436969B1 (en) | 1995-09-12 | 2002-08-20 | Kansas University Medical Center Research Institute Inc. | Dialysis solutions and methods |
JPH09194375A (ja) * | 1996-01-17 | 1997-07-29 | Senju Pharmaceut Co Ltd | 免疫抑制作用増強剤 |
US6610206B1 (en) | 1998-10-20 | 2003-08-26 | Advanced Renal Technologies | Buffered compositions for dialysis |
US7670491B2 (en) * | 1998-10-20 | 2010-03-02 | Advanced Renal Technologies | Buffered compositions for dialysis |
WO2000051987A2 (en) | 1999-03-05 | 2000-09-08 | Kansas University Medical Center | Inhibitors of advanced, post-amadori glycosylation reactions |
EP2052751A3 (de) * | 1999-09-22 | 2009-06-03 | Advanced Renal Technologies | Anwendung eines Dialysats mit hohem Zitratgehalt |
AUPR549901A0 (en) | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
EP1420797A4 (de) | 2001-07-27 | 2005-03-02 | Vital Health Sciences Pty Ltd | Hauttherapie unter verwendung von phosphatderivaten von elektronentransfermitteln |
AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
SE0400523D0 (sv) | 2004-03-01 | 2004-03-01 | Gambro Lundia Ab | A medical solution, a method for producing said medical solution and use thereof |
WO2005084678A1 (en) | 2004-03-03 | 2005-09-15 | Vital Health Sciences Pty Ltd | Alkaloid formulations |
KR101037152B1 (ko) * | 2004-04-23 | 2011-05-26 | 엘지전자 주식회사 | 세탁기의 제어 방법 |
SE0402507D0 (sv) | 2004-10-14 | 2004-10-14 | Gambro Lundia Ab | Medicinsk lösning, förfarande för framställning och användning därav |
EP1861091B1 (de) * | 2005-03-03 | 2013-12-11 | Vital Health Sciences Pty Ltd. | Verbindungen mit lipidsenkenden eigenschaften |
ES2557475T3 (es) | 2005-06-17 | 2016-01-26 | Vital Health Sciences Pty Ltd. | Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones |
WO2011094814A1 (en) | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
ES2829386T3 (es) | 2010-03-30 | 2021-05-31 | Phosphagenics Ltd | Parche de administración transdérmica |
EP2685992A4 (de) | 2011-03-15 | 2014-09-10 | Phosphagenics Ltd | Aminochinoline als kinasehemmer |
US10973761B2 (en) | 2015-12-09 | 2021-04-13 | Phosphagenics Limited | Pharmaceutical formulation |
CN110662733A (zh) | 2016-12-21 | 2020-01-07 | 埃维科生物技术有限公司 | 方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH25859A (en) * | 1988-01-11 | 1991-12-02 | Takeda Chemical Industries Ltd | Composition for treatment of ischemic disorder |
ES2058891T3 (es) * | 1989-02-02 | 1994-11-01 | Senju Pharma Co | Preparacion liquida para perfusion intraocular. |
JP2854631B2 (ja) * | 1989-11-21 | 1999-02-03 | 千寿製薬株式会社 | 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤 |
ATE149682T1 (de) * | 1991-12-04 | 1997-03-15 | Bertin & Cie | Verfahren und vorrichtung zur optischen ferndetektion eines sich in einem beobachteten raumgebiet befindenden gases |
-
1994
- 1994-08-04 CA CA002129509A patent/CA2129509A1/en not_active Abandoned
- 1994-08-06 TW TW083107224A patent/TW298566B/zh active
- 1994-08-31 US US08/302,192 patent/US5474992A/en not_active Expired - Fee Related
- 1994-09-07 DE DE69414947T patent/DE69414947T2/de not_active Expired - Fee Related
- 1994-09-07 EP EP94113993A patent/EP0643969B1/de not_active Expired - Lifetime
- 1994-09-07 AT AT94113993T patent/ATE173928T1/de not_active IP Right Cessation
- 1994-09-07 ES ES94113993T patent/ES2124348T3/es not_active Expired - Lifetime
- 1994-09-09 KR KR1019940022796A patent/KR950007845A/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ATE173928T1 (de) | 1998-12-15 |
KR950007845A (ko) | 1995-04-15 |
TW298566B (de) | 1997-02-21 |
ES2124348T3 (es) | 1999-02-01 |
US5474992A (en) | 1995-12-12 |
EP0643969A3 (de) | 1996-03-13 |
DE69414947T2 (de) | 1999-07-08 |
EP0643969B1 (de) | 1998-12-02 |
EP0643969A2 (de) | 1995-03-22 |
CA2129509A1 (en) | 1995-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69414947D1 (de) | Dialyselösung zur extrakorporalen Hemodialyse | |
BR0014179A (pt) | Modernos derivados de ácido aminodicarboxìlico com propriedades farmacêuticas | |
TNSN01035A1 (fr) | Derives d'ethers de pyrazole nouveaux, et compositions pharmaceutiques les contenant. | |
TNSN98036A1 (fr) | Derives d'acide hexanoique nouveaux | |
DE60024415D1 (de) | Die glycin-betain für seine antithrombotische verwendung | |
BR9910122A (pt) | Compostos amidina | |
HRP20050843A2 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds | |
DE69024826D1 (de) | Aza-Macrozyklen und Verfahren zu deren Herstellung | |
SI21169B (sl) | Nova uporaba peptidnega razreda spojine za zdravljenje alodinije ali drugih razliäśnih vrst kroniäśne ali fantomske boleäśine | |
TNSN01124A1 (fr) | Derives de 1,4-dihydropyridine nouveaux , servant d'antagonistes de la bradykinine, et compositions les contenant | |
BR0013065A (pt) | Método e composto para tratar de uma doença associada com recrutamento e/ ou ativação aberrante de leucócitos | |
EP0276376A3 (de) | Anordnung zur Vorbereitung einer Flüssigkeit für eine medizinische Behandlung | |
NO20040520L (no) | Heterocykliske derivater som inhiberer faktor XA | |
NO20005497L (no) | Heterocykliske derivater som inhiberer faktor Xa | |
ATE187642T1 (de) | Verwendund von norastemizol zur behandlung der allergischen rhinitis | |
DE69923444D1 (de) | Heterozyklische verbindungen mit faktor xa hemmender wirkung | |
DK1289535T3 (da) | Apoptotiske enheder til anvendelse ved behandling af neurodegenerative og andre neurologiske sygdomme | |
ATE290384T1 (de) | Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen | |
DE60108130D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten | |
JP4390023B2 (ja) | 過酢酸組成物 | |
AR043003A1 (es) | Compuestos (benzoimidazol-2-il) fenilaminas n-sustituidas, procedimiento para su preparacion, su uso como farmacos o como ayuda en diagnostico, y los medicamentos que las contienen | |
Oakley et al. | The use of dialysis bath fluid as a vehicle for a drug with a narrow therapeutic index—Lithium chloride | |
KR900013956A (ko) | 디메르캅토숙신산(dmsa)으로 규소를 감소시키는 방법 | |
ATE464051T1 (de) | Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz | |
Baloch et al. | Nephritis and charcot-marie-tooth disease: an unusual association |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |